Financial Review: Tilray (NASDAQ:TLRY) & Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR)

Tilray (NASDAQ:TLRY) and Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

Valuation & Earnings

This table compares Tilray and Synergy CHC Corp. (Uplisting)”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray	$210.48 million	2.87	-$244.98 million	($0.30)	-2.15
Synergy CHC Corp. (Uplisting)	$26.01 million	1.20	N/A	N/A	N/A

Synergy CHC Corp. (Uplisting) has lower revenue, but higher earnings than Tilray.

Insider & Institutional Ownership

9.4% of Tilray shares are held by institutional investors. 0.9% of Tilray shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Tilray and Synergy CHC Corp. (Uplisting)’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tilray	-30.95%	-4.40%	-3.57%
Synergy CHC Corp. (Uplisting)	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Tilray and Synergy CHC Corp. (Uplisting), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray	0	3	2	0	2.40
Synergy CHC Corp. (Uplisting)	0	0	1	1	3.50

Tilray presently has a consensus target price of $2.70, indicating a potential upside of 318.93%. Synergy CHC Corp. (Uplisting) has a consensus target price of $10.00, indicating a potential upside of 179.33%. Given Tilray’s higher possible upside, research analysts clearly believe Tilray is more favorable than Synergy CHC Corp. (Uplisting).

Summary

Tilray beats Synergy CHC Corp. (Uplisting) on 6 of the 11 factors compared between the two stocks.

About Tilray

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

About Synergy CHC Corp. (Uplisting)

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.